ProPhase Labs Valuation
| PRPH Stock | USD 0.16 0.01 5.88% |
ProPhase Labs seems to be undervalued based on Macroaxis valuation methodology. Our model determines the value of ProPhase Labs from analyzing the company fundamentals such as Current Valuation of 8.08 M, shares owned by insiders of 5.05 %, and Return On Equity of -2.2 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ProPhase Labs' valuation include:
Price Book 0.1174 | Enterprise Value | Enterprise Value Ebitda 2.4498 | Price Sales 0.1556 | Forward PE 10.0908 |
Undervalued
Today
Please note that ProPhase Labs' price fluctuation is dangerous at this time. Calculation of the real value of ProPhase Labs is based on 3 months time horizon. Increasing ProPhase Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ProPhase Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProPhase Stock. However, ProPhase Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.16 | Real 3.57 | Target 13.8 | Hype 0.17 | Naive 0.27 |
The intrinsic value of ProPhase Labs' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ProPhase Labs' stock price.
Estimating the potential upside or downside of ProPhase Labs helps investors to forecast how ProPhase stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProPhase Labs more accurately as focusing exclusively on ProPhase Labs' fundamentals will not take into account other important factors: When choosing an evaluation method for ProPhase Labs, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
ProPhase Labs Cash |
|
ProPhase Labs Total Value Analysis
ProPhase Labs is at this time projected to have valuation of 8.08 M with market capitalization of 786.34 K, debt of 24.57 M, and cash on hands of 27.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ProPhase Labs fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.08 M | 786.34 K | 24.57 M | 27.5 M |
ProPhase Labs Investor Information
The company has price-to-book ratio of 0.12. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ProPhase Labs recorded a loss per share of 19.8. The entity last dividend was issued on the 24th of May 2022. The firm had 1:10 split on the 22nd of December 2025. Based on the key indicators related to ProPhase Labs' liquidity, profitability, solvency, and operating efficiency, ProPhase Labs is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.ProPhase Labs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ProPhase Labs has an asset utilization ratio of 10.71 percent. This signifies that the Company is making $0.11 for each dollar of assets. An increasing asset utilization means that ProPhase Labs is more efficient with each dollar of assets it utilizes for everyday operations.ProPhase Labs Profitability Analysis
Based on ProPhase Labs' profitability indicators, ProPhase Labs may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess ProPhase Labs' ability to earn profits and add value for shareholders.Net Loss | First Reported 1996-12-31 | Previous Quarter -4.5 M | Current Value -6.8 M | Quarterly Volatility 6 M |
For ProPhase Labs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ProPhase Labs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ProPhase Labs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ProPhase Labs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ProPhase Labs over time as well as its relative position and ranking within its peers.
ProPhase Labs Earnings per Share Projection vs Actual
By analyzing ProPhase Labs' earnings estimates, investors can diagnose different trends across ProPhase Labs' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for ProPhase Labs is based on EPS before non-recurring items and includes expenses related to employee stock options.ProPhase Labs Ownership Allocation
ProPhase Labs holds 5.05 pct. of its outstanding shares held by insiders and 3.95 pct. owned by third-party entities.ProPhase Labs Profitability Analysis
The company reported the previous year's revenue of 6.77 M. Net Loss for the year was (49.52 M) with profit before overhead, payroll, taxes, and interest of 987 K.About ProPhase Labs Valuation
An absolute valuation paradigm, as applied to ProPhase Stock, attempts to find the value of ProPhase Labs based on its fundamental and basic technical indicators. By analyzing ProPhase Labs's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ProPhase Labs's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ProPhase Labs. We calculate exposure to ProPhase Labs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ProPhase Labs's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -135 K | -128.2 K | |
| Pretax Profit Margin | (7.19) | (6.83) | |
| Operating Profit Margin | (6.56) | (6.23) | |
| Net Loss | (9.06) | (8.61) | |
| Gross Profit Margin | (0.03) | (0.02) |
ProPhase Labs Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.9 M | |
| Quarterly Earnings Growth Y O Y | -0.952 | |
| Forward Price Earnings | 10.0908 |
ProPhase Labs Current Valuation Indicators
Valuation refers to the process of determining the present value of ProPhase Labs and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ProPhase we look at many different elements of the entity such as ProPhase's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ProPhase Labs, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ProPhase Labs' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ProPhase Labs' worth.Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |